| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |